Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexin-1 Receptor-Cannabinoid CB1 Receptor Heterodimerization Results in Both Ligand-dependent and -independent Coordinated Alterations of Receptor Localization and Function
James Ellis, John D. Pediani, Meritxell Canals, et al.
Journal of Biological Chemistry (2006) Vol. 281, Iss. 50, pp. 38812-38824
Open Access | Times Cited: 219

Showing 26-50 of 219 citing articles:

AT1R-CB1R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II
Raphaël Rozenfeld, Achla Gupta, Khatuna Gagnidze, et al.
The EMBO Journal (2011) Vol. 30, Iss. 12, pp. 2350-2363
Open Access | Times Cited: 141
Physiology of the orexinergic/hypocretinergic system: a revisit in 2012
Jyrki P. Kukkonen
AJP Cell Physiology (2012) Vol. 304, Iss. 1, pp. C2-C32
Closed Access | Times Cited: 133
Orexin/hypocretin receptor signalling: a functional perspective
Christopher S. Leonard, Jyrki P. Kukkonen
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 294-313
Open Access | Times Cited: 126
Formation of μ-/κ-opioid receptor heterodimer is sex-dependent and mediates female-specific opioid analgesia
Sumita Chakrabarti, Nai‐Jiang Liu, Alan R. Gintzler
Proceedings of the National Academy of Sciences (2010) Vol. 107, Iss. 46, pp. 20115-20119
Open Access | Times Cited: 126
The apelin receptor inhibits the angiotensin II type 1 receptor via allosteric trans‐inhibition
Khandaker Siddiquee, Jessica Hampton, Danielle McAnally, et al.
British Journal of Pharmacology (2012) Vol. 168, Iss. 5, pp. 1104-1117
Open Access | Times Cited: 124
The role of the endocannabinoid system in the neuroendocrine regulation of energy balance
Francisco J. Bermúdez‐Silva, Pierre Cardinal, Daniela Cota
Journal of Psychopharmacology (2011) Vol. 26, Iss. 1, pp. 114-124
Closed Access | Times Cited: 114
Endocannabinoid signaling and food addiction
Claudio D’Addario, Maria Vittoria Micioni Di Bonaventura, Mariangela Pucci, et al.
Neuroscience & Biobehavioral Reviews (2014) Vol. 47, pp. 203-224
Closed Access | Times Cited: 111
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
Estefanía Moreno, Milena Čavić, Ana Krivokuća, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 110
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
Estefanía Moreno, Clara Andradas, Mireia Medrano, et al.
Journal of Biological Chemistry (2014) Vol. 289, Iss. 32, pp. 21960-21972
Open Access | Times Cited: 105
Cannabinoids Exacerbate Alcohol Teratogenesis by a CB1-Hedgehog Interaction
Eric W. Fish, Laura B. Murdaugh, Chengjin Zhang, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 98
Allosteric Transinhibition by Specific Antagonists in CCR2/CXCR4 Heterodimers
Denis Sohy, Marc Parmentier, Jean–Yves Springael
Journal of Biological Chemistry (2007) Vol. 282, Iss. 41, pp. 30062-30069
Closed Access | Times Cited: 145
μ-Opioid Receptor Forms a Functional Heterodimer With Cannabinoid CB1 Receptor: Electrophysiological and FRET Assay Analysis
Minoru Hojo, Yuka Sudo, Yukio Ando, et al.
Journal of Pharmacological Sciences (2008) Vol. 108, Iss. 3, pp. 308-319
Open Access | Times Cited: 138
The complications of promiscuity: endocannabinoid action and metabolism
S P H Alexander, Dave Kendal
British Journal of Pharmacology (2007) Vol. 152, Iss. 5, pp. 602-623
Open Access | Times Cited: 133
Dopamine D1-histamine H3 Receptor Heteromers Provide a Selective Link to MAPK Signaling in GABAergic Neurons of the Direct Striatal Pathway
Estefanía Moreno, Hanne M. Hoffmann, Marta González-Sepúlveda, et al.
Journal of Biological Chemistry (2010) Vol. 286, Iss. 7, pp. 5846-5854
Open Access | Times Cited: 117
Cannabinoid CB1 receptor‐interacting proteins: novel targets for central nervous system drug discovery?
Tricia H. Smith, Laura J. Sim‐Selley, Dana E. Selley
British Journal of Pharmacology (2010) Vol. 160, Iss. 3, pp. 454-466
Open Access | Times Cited: 116
A day in the life of a G protein‐coupled receptor: the contribution to function of G protein‐coupled receptor dimerization
George Milligan
British Journal of Pharmacology (2007) Vol. 153, Iss. S1
Open Access | Times Cited: 112
Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes
Vincenzo Di Marzo, Fabiana Piscitelli, Raphael Mechoulam
Handbook of experimental pharmacology (2011), pp. 75-104
Closed Access | Times Cited: 111
Cannabinoids and the Brain
Attila Köfalvi
Springer eBooks (2007)
Closed Access | Times Cited: 109
Conserved Polar Residues in Transmembrane Domains V, VI, and VII of Free Fatty Acid Receptor 2 and Free Fatty Acid Receptor 3 Are Required for the Binding and Function of Short Chain Fatty Acids
Leigh A. Stoddart, Nicola J. Smith, Laura Jenkins, et al.
Journal of Biological Chemistry (2008) Vol. 283, Iss. 47, pp. 32913-32924
Open Access | Times Cited: 108
Ligand- and Heterodimer-Directed Signaling of the CB1 Cannabinoid Receptor
Brian D. Hudson, Terence E. Hébert, Michael E. Kelly
Molecular Pharmacology (2009) Vol. 77, Iss. 1, pp. 1-9
Closed Access | Times Cited: 102
Functional characterization of putative cholesterol binding sequence (CRAC) in human type‐1 cannabinoid receptor
Sergio Oddi, Enrico Dainese, Filomena Fezza, et al.
Journal of Neurochemistry (2011) Vol. 116, Iss. 5, pp. 858-865
Closed Access | Times Cited: 100
Signal Transduction via Cannabinoid Receptors
George D. Dalton, Caroline E. Bass, Cynthia Van Horn, et al.
CNS & Neurological Disorders - Drug Targets (2009) Vol. 8, Iss. 6, pp. 422-431
Open Access | Times Cited: 92
Heteromultimerization of Cannabinoid CB1 Receptor and Orexin OX1 Receptor Generates a Unique Complex in Which Both Protomers Are Regulated by Orexin A
Richard J. Ward, John D. Pediani, Graeme Milligan
Journal of Biological Chemistry (2011) Vol. 286, Iss. 43, pp. 37414-37428
Open Access | Times Cited: 91
Type-1 Cannabinoid Receptor Signaling in Neuronal Development
Anne-Lise Gaffuri, Delphine Ladarré, Zsolt Lenkei
Pharmacology (2012) Vol. 90, Iss. 1-2, pp. 19-39
Open Access | Times Cited: 88
The Cannabinoid Receptor CB1 Modulates the Signaling Properties of the Lysophosphatidylinositol Receptor GPR55
Julia Kargl, Nariman Balenga, Gerald P. Parzmair, et al.
Journal of Biological Chemistry (2012) Vol. 287, Iss. 53, pp. 44234-44248
Open Access | Times Cited: 87

Scroll to top